From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jun 11, 2002
MDL No. 1290 (TFH), Misc. No. 99ms276, Case No.: 1:99CV00790, Consolidated with Case No. 99 C 2228 (D.D.C. Jun. 11, 2002)

Opinion

MDL No. 1290 (TFH), Misc. No. 99ms276, Case No.: 1:99CV00790, Consolidated with Case No. 99 C 2228

June 11, 2002


ORDER


WHEREAS, the Court having reviewed and considered the Motion to File Pleading under Seal,

IT IS HEREBY ORDERED:

1. That the Class Plaintiffs' Reply to Mylan's Further Supplemental Memorandum in Opposition to Plaintiffs' Motion to Quash and supporting exhibit shall be filed by the Clerk under seal.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jun 11, 2002
MDL No. 1290 (TFH), Misc. No. 99ms276, Case No.: 1:99CV00790, Consolidated with Case No. 99 C 2228 (D.D.C. Jun. 11, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:In re Lorazepam Clorazepate Antitrust Litigation ADVOCATE HEALTH CARE, et…

Court:United States District Court, D. Columbia

Date published: Jun 11, 2002

Citations

MDL No. 1290 (TFH), Misc. No. 99ms276, Case No.: 1:99CV00790, Consolidated with Case No. 99 C 2228 (D.D.C. Jun. 11, 2002)